8 Ex-Dividend Stocks With Buy Ratings
NEW YORK (TheStreet) -- The following stocks go ex-dividend Wednesday, meaning an investor must purchase the shares Tuesday to qualify for the next dividend payment: Abbott Laboratories (ABT), Buckle (BKE), Freeport-McMoran (FCX), Foot Locker (FL), General Dynamics (GD), Goldcorp (GG), Morningstar (MORN) and Yum Brands (YUM).
Each of the stocks received a buy rating from TheStreet Ratings.
![]() |
Abbott Laboratories
The health care company is scheduled to report its first-quarter earnings on April 17. Analysts, on average, anticipate earnings of 99 cents a share on revenue of $9.35 billion.
"Due to the release of the ABT abstract on HCV yesterday and due to the improvement in the valuations of ABT's comps we are updating our sum of the parts valuation model for ABT today," Bank of America Merrill Lynch analysts wrote in an April 5 report. "On the encouraging co-pilot data we are increasing the earnings multiple we assume for ABT's pharma business to 11 from 10. We continue to use a 14 multiple for the diversified medical products business based on our sum of the parts of the four businesses within that division that we show below. And we are now basing our target multiples on 2013 estimates. As a result our PO moves from $57 to $65." Forward Annual Dividend Yield: 3.3% Rated "A (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was about the same as it was last year. Abbott Laboratories has average liquidity. Its Quick Ratio is 1.02, which shows the company can technically meet its short-term cash needs. In the fourth quarter, stockholders' net worth increased 9.16% from the prior year. TheStreet Ratings' price target is $75.25.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
